2025³â 08¿ù 09ÀÏ Åä¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92622°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



Çö´ëÂ÷, Çë°¡¸® ¼ö¿äÀÀ´ä±³Åë ½Ã¹ü»ç¾÷ Âü¿©

¼ÅŬ Ç÷§Æû ±Û·Î¹ú »ç¾÷ È®Àå ±â¹Ý ¸¶·Ã
Çö´ëÂ÷°¡ Çë°¡¸®¿¡¼­ Áö¿ª ±³Åë ¹®Á¦¸¦ ÇØ°áÇϱâ À§ÇÑ ¼ö¿äÀÀ´ä±³Åë(Demand Responsive Transport, DRT) ¿î¿µ ½Ã¹ü»ç¾÷¿¡ Âü¿©ÇÑ´Ù. ±¹³» ¼º°øÀûÀÎ ¼ö¿äÀÀ´ä±³Åë ¼­ºñ½º Á¦°ø °æÇèÀ» ¹ÙÅÁÀ¸·Î ±Û·Î¹ú ½ÃÀåÀ¸·Î ¼­ºñ½º È®´ë¸¦ ÃßÁøÇÑ´Ù´Â Á¡¿¡¼­ Àǹ̰¡ ÀÖ´Ù. Çö´ëÀÚµ¿Â÷´Â Áö³­´Þ 31ÀÏ(ÇöÁö½Ã°¢) Çë°¡¸® ±«µÉ·Ú(Gödöllő)½Ã¿¡¼­ ¿­¸° ‘Çë°¡¸® ¼ö¿äÀÀ´ä±³Åë ¼­ºñ½º °³Åë½Ä’¿¡¼­ ÃÖ÷´Ü ¼ö¿äÀÀ´ä±³Åë Ç÷§ÆûÀ» Á¦°øÇϰí, ±Û·Î¹ú »ç¾÷ È®Àå ±â¹ÝÀ» ¸¶·ÃÇÑ´Ù°í 3ÀÏ(ÀÏ) ¹àÇû´Ù. °³Åë½Ä¿¡ µû¶ó 8¿ù 18ÀϺÎÅÍ 10¿ù ...

¡®±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡¡¯ ¸ðÁý¡¦ÀÏ±Þ 100¸¸¿ø

ÀâÄÚ¸®¾Æx¾Ë¹Ù¸óxǪ¶ó´ß º¹³¯ ÀÌ»ö¾Ë¹Ù
ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸ó(´ëÇ¥ÀÌ»ç À±ÇöÁØ)ÀÌ º¹³¯À» ¸Â¾Æ ġŲ Àü¹® ºê·£µå Ǫ¶ó´ß ġŲ°ú ÇÔ²² ÀÌ»ö ¾Ë¹Ù¸¦ ¸ðÁýÇÏ´Â À̺¥Æ®¸¦ ÁøÇàÇÑ´Ù°í 21ÀÏ ¹àÇû´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ³»´Þ 3ÀϱîÁö Ǫ¶ó´ß ġŲ°ú Çù¾÷ÇØ º¹³¯ ±â³ä ÀÌ»ö °ø°í¸¦ ³»°í ‘±ñdzġŲ »À ¹Ù¸¦ ¾Ë¹Ù¸ó’°ú ‘±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡’¸¦ ¸ðÁýÇÑ´Ù. À̹ø À̺¥Æ®´Â ¾Ë¹Ù¸óÀÌ ÁøÇà ÁßÀÎ ´ë±Ô¸ð ÇÁ·Î¸ð¼Ç ‘2025 ¿©¸§ ¾Ë¹Ù Æä½ºÅ¸(¿©¾ËÆä)’ÀÇ ÀÏȯÀÌ´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ¿©¸§Ã¶ ¹«´õÀ§¿Í ²ß²ßÇÑ ³¯¾¾·Î ÁöÃÄ ÀÖ´Â ±¸Á÷ÀÚµéÀ» À§ ...

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...
¼­¿ï´ë °ø´ë-¼­¿ï´ë±â¼úÁöÁÖ, À¯¸Á Å×Å©±â¾÷ ¹ß±¼ ¹× ÅõÀÚ Çù¾à (2024-02-03)
Çö´ë¡¤±â¾ÆÀÚµ¿Â÷ 3°³ Â÷Á¾ 28954´ë ¸®ÄÝ (2016-04-18)
½¦º¸·¹, ¾Æº£¿À ½ºÆ÷Ã÷ ÆÐŰÁö Ãâ½Ã (2014-06-16)
ĵ½ºÅæ T280X¡¤FX5021 »ç¿îµå¹Ù (2022-02-25)
SK¢ß C&C, Á¦Á¶¾÷ ÇöÀå¿¡¼­µµ »ý¼ºÇü AI Ȱ¿ë µ½´Â´Ù (2023-11-18)
LGÈ­ÇÐ, 2017³â 1ºÐ±â »ç»ó ÃÖ´ë ¸ÅÃâ (2017-04-22)
µµ·Î±³Åë°ø´Ü, °ø±ººÎ´ë ³» µµ·Î±³Åë¾ÈÀü½Ã¼³ Á¡°Ë (2015-05-15)
±èÁßÀ§ Àü Àå°ü, Çѱ¹¹®¿¹ÇмúÀúÀÛ±ÇÇùȸÀå ÃëÀÓ (2020-04-29)
Â÷¼±ÀÌÅ»¹æÁöÀåÄ¡ ÀåÂø ½Ã ÇÒÀÎÇØÁÖ´Â º¸ÇèÆ¯¾à (2018-01-24)
¿¡±×µå¶ø, ºê·£µå ÀÔÁö ´ÙÁö¸ç °¡¸ÍÁ¡ È®À塤Áö¿ø (2023-05-07)
Glucophage Is the First Oral Diabetes Treatment Approved in ... (2022-03-02)
ÃÖÀÎ ±âŸ ¸®»çÀÌÆ² ¡®Musicscape¡¯ (2017-10-08)
µ¿½É¿¬±¸¼Ò, ±¹³»¡¤¿Ü ¿µÀ¯¾Æ ±³À°Áö¿ø... »çȸ°øÇå Ȱµ¿ (2024-02-08)
IBK±â¾÷ÀºÇà, ¡®´ëÇѹα¹ ÃÖ¿ì¼ö Áß¼Ò±â¾÷±ÝÀ¶ ÀºÇà»ó¡¯ ¼ö»ó (2024-02-08)
±¤ÁÖU´ëȸ D-500ÀÏ, ½ÇÀüÁغñüÁ¦ µ¹ÀÔ (2014-02-17)
Çѱ¹ÀÎ, ÀÚÀ²ÁÖÇàÂ÷ ºÒ¾ÈÇϰí ȫäÀνĵµ ¾È½É ¸ø ÇØ (2017-06-17)
¹è¿ì ±èÅÂÈñ, ¼â°ñ µå·¯³½ ¡®Å»ڡ¯Ç¥ ¸ÅȤ¹Ì (2016-03-07)
°­½ºÅÛ¹ÙÀÌ¿ÀÅØ, JP¸ð°Ç ÄÜÆÛ·±½º ºòµô ½Åȣź µÇ³ª (2023-01-14)
Çö´ëÀÚµ¿Â÷, ¡®¿òÁ÷ÀÓÀÇ ¹ÌÇС¯ Àü½Ãȸ (2015-12-21)
¹®È­Àç ¡®µµÁ¤±Ã °æ¿ø´ç¡¯ º¹¿ø Áذø½Ä (2014-10-21)
³ë½ºÆäÀ̽º, ¡®2021 ŰÁî ¾îÅÒ Ä÷º¼Ç¡¯ Ãâ½Ã (2021-10-04)
L&T Technology Services and Qualcomm Selected by Thales for ... (2023-02-24)
»ç¾÷ü 10°÷ Áß 2°÷, À¯¿¬±Ù¹«Á¦µµ µµÀÔ (2016-12-14)
Áß±¹ ¿ÕÈ«, Çѱ¹Á¶Æó°ø»ç ¹æ¹® (2016-12-14)
½ºÅ¸Æ®¾÷ ±â¾÷ ´å, ¿¬´Þ¾Æ ±¹Á¦ ±¤°í»ó (2016-12-19)
       [ÀÌÀü][1]....[1443][1444][1445][1446][1447][1448][1449][1450][1451]...[3705][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..